These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2548146)

  • 1. In situ and in vitro evidence for intragenic binding of nuclear factors at the murine c-myc locus.
    Tourkine N; Mechti N; Piechaczyk M; Jeanteur P; Blanchard JM
    Oncogene; 1989 Aug; 4(8):973-8. PubMed ID: 2548146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered myc gene transcription and intron-induced stabilization of myc RNAs in two mouse plasmacytomas.
    Bauer SR; Piechaczyk M; Nordan RP; Owens JD; Nepveu A; Marcu KB; Mushinski JF
    Oncogene; 1989 May; 4(5):615-23. PubMed ID: 2657576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
    Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-myc and c-fos gene regulation during mouse liver regeneration.
    Sobczak J; Mechti N; Tournier MF; Blanchard JM; Duguet M
    Oncogene; 1989 Dec; 4(12):1503-8. PubMed ID: 2512526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M; Boss GR; Pascual FE; Pilz RB
    Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The block of elongation in c-myc exon 1 is abolished in Burkitt's lymphoma cell lines with variant translocation.
    Eick D; Polack A; Kofler E; Bornkamm GW
    Oncogene; 1988 Oct; 3(4):397-403. PubMed ID: 3078949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-specific post-transcriptional regulation of c-myc expression in normal and H-2K/human c-myc transgenic mice.
    Morello D; Asselin C; Lavenu A; Marcu KB; Babinet C
    Oncogene; 1989 Aug; 4(8):955-61. PubMed ID: 2668846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two transient increases in c-myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells.
    St-Arnaud R; Nepveu A; Marcu KB; McBurney MW
    Oncogene; 1988 Nov; 3(5):553-9. PubMed ID: 3078960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cellular oncogenes: unrearranged c-myc gene but altered promoter usage in radiation-induced thymoma.
    Bandyopadhyay SK; D'Andrea E; Fleissner E
    Oncogene Res; 1989; 4(4):311-8. PubMed ID: 2475843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated expression of c-myc and N-myc produces distinct changes in nuclear fine structure and chromatin organization.
    Henriksson M; Classon M; Ingvarsson S; Koskinen P; Sümegi J; Klein G; Thyberg J
    Oncogene; 1988 Nov; 3(5):587-93. PubMed ID: 3078963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells.
    Bentley DL; Groudine M
    Nature; 1986 Jun 12-18; 321(6071):702-6. PubMed ID: 3520340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of c-myb gene regulation in MRL-lpr/lpr mice. Identification of a 5' c-myb nuclear protein binding site and high levels of binding factors in nuclear extracts of lpr/lpr lymph node cells.
    Mountz JD; Steinberg AD
    J Immunol; 1989 Jan; 142(1):328-35. PubMed ID: 2642505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a second promoter in the human c-myb proto-oncogene.
    Jacobs SM; Gorse KM; Westin EH
    Oncogene; 1994 Jan; 9(1):227-35. PubMed ID: 8302584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mode of c-myc gene regulation in folic acid-induced kidney regeneration.
    Asselin C; Marcu KB
    Oncogene Res; 1989; 5(1):67-72. PubMed ID: 2476708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolutionary conservation of the product of human c-myc exon 1 and its inducible expression in a murine cell line.
    Dedieu JF; Gazin C; Rigolet M; Galibert F
    Oncogene; 1988 Nov; 3(5):523-9. PubMed ID: 3078958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ECA39 is regulated by c-Myc in human and by a Jun/Fos homolog, Gcn4, in yeast.
    Ben-Yosef T; Yanuka O; Benvenisty N
    Oncogene; 1996 Nov; 13(9):1859-66. PubMed ID: 8934531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation in megakaryocytes: the thrombopoietin receptor gene as a model.
    Mignotte V; Deveaux S; Filipe A
    Stem Cells; 1996; 14 Suppl 1():232-9. PubMed ID: 11012226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The GATA-1 and Spi-1 transcriptional factors bind to a GATA/EBS dual element in the Fli-1 exon 1.
    Barbeau B; Barat C; Bergeron D; Rassart E
    Oncogene; 1999 Sep; 18(40):5535-45. PubMed ID: 10523830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1.
    Hewitt SM; Hamada S; McDonnell TJ; Rauscher FJ; Saunders GF
    Cancer Res; 1995 Nov; 55(22):5386-9. PubMed ID: 7585606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistence of a c-myc mRNA initiated in intron 1 with the normal c-myc mRNA and similar regulation of both transcripts in mammalian cells.
    Ray D; Robert-Lézénès J
    Oncogene Res; 1989; 5(1):73-8. PubMed ID: 2674860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.